Platform Specialty Products Corporation produces and sells specialty chemical products worldwide. It operates through two segments, Performance Solutions and Agricultural Solutions. The Performance Solutions segment offers a range of specialty chemicals, such as surface and coating materials, functional conversion coatings, electronic assembly materials, water-based hydraulic control fluids, and photopolymers. The Agricultural Solutions segment engages in the development, formulation, registration, marketing, and distribution of crop protection solutions, including BioSolutions products and seed treatments for various crops and applications. This segment also offers crop protection chemicals that control biotic stresses, such as fungicides, herbicides, and insecticides. It serves agricultural, animal health, electronics, graphics, plating, offshore oil and gas production, and drilling industries. The company was formerly known as Platform Acquisition Holdings Limited and changed its name to Platform Specialty Products Corporation in October 2013. Platform Specialty Products Corporation was founded in 1922 and is headquartered in West Palm Beach, Florida.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Miscellaneous chemical products
Sub-IndustryN/A
SectorBasic Materials
Current SymbolNYSE:PAH
Previous Symbol
CUSIPN/A
Phone561-207-9600
Debt
Debt-to-Equity Ratio2.55
Current Ratio2.19
Quick Ratio2.00
Price-To-Earnings
Trailing P/E Ratio14.07
Forward P/E Ratio38.18
P/E Growth17.21
Sales & Book Value
Annual Sales$3.78 billion
Price / Sales0.82
Cash Flow$2.6010 per share
Price / Cash4.11
Book Value$7.32 per share
Price / Book1.46
Profitability
EPS (Most Recent Fiscal Year)$0.76
Net Income$-296,200,000.00
Net Margins-14.14%
Return on Equity8.48%
Return on Assets2.23%
Miscellaneous
Employees7,850
Outstanding Shares288,330,000
Market Cap$3.06 billion
OptionableOptionable
Platform Specialty Products (NYSE:PAH) Frequently Asked Questions
What is Platform Specialty Products' stock symbol?
Platform Specialty Products trades on the New York Stock Exchange (NYSE) under the ticker symbol "PAH."
How were Platform Specialty Products' earnings last quarter?
Platform Specialty Products Corp (NYSE:PAH) released its earnings results on Thursday, November, 1st. The specialty chemicals company reported $0.04 EPS for the quarter, hitting the Thomson Reuters' consensus estimate of $0.04. The specialty chemicals company earned $488.50 million during the quarter, compared to analysts' expectations of $500.69 million. Platform Specialty Products had a negative net margin of 14.14% and a positive return on equity of 8.48%. The business's revenue was up 1.6% on a year-over-year basis. During the same quarter last year, the business earned $0.02 EPS. View Platform Specialty Products' Earnings History.
When is Platform Specialty Products' next earnings date?
What price target have analysts set for PAH?
5 equities research analysts have issued twelve-month target prices for Platform Specialty Products' shares. Their forecasts range from $12.00 to $15.00. On average, they expect Platform Specialty Products' share price to reach $12.75 in the next twelve months. This suggests a possible upside of 19.3% from the stock's current price. View Analyst Price Targets for Platform Specialty Products.
What is the consensus analysts' recommendation for Platform Specialty Products?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Platform Specialty Products in the last year. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Platform Specialty Products.
Has Platform Specialty Products been receiving favorable news coverage?
Press coverage about PAH stock has been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Platform Specialty Products earned a news impact score of -1.8 on InfoTrie's scale. They also gave news stories about the specialty chemicals company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future.
Who are some of Platform Specialty Products' key competitors?
Who are Platform Specialty Products' key executives?
Platform Specialty Products' management team includes the folowing people:
- Mr. Martin Ellis Franklin, Founder & Chairman (Age 53)
- Mr. Rakesh Sachdev, CEO & Director (Age 62)
- Mr. John P. Connolly, Chief Financial Officer (Age 52)
- Mr. Benjamin Gliklich, Exec. VP of Operations & Strategy (Age 33)
- Mr. John Edwards Capps, Exec. VP, Gen. Counsel & Sec. (Age 53)
Who are Platform Specialty Products' major shareholders?
Platform Specialty Products' stock is owned by many different of institutional and retail investors. Top institutional shareholders include FMR LLC (12.22%), BlackRock Inc. (5.54%), Dimensional Fund Advisors LP (5.34%), Credit Suisse AG (4.14%), Victory Capital Management Inc. (1.29%) and Vaughan Nelson Investment Management L.P. (1.08%). Company insiders that own Platform Specialty Products stock include Benjamin Gliklich, Diego Lopez Casanello, Ian G H Ashken, John David Tolbert, John Edward Capps, Martin E Franklin, Pershing Square Capital Manage, Rakesh Sachdev and Scot Benson. View Institutional Ownership Trends for Platform Specialty Products.
Which major investors are selling Platform Specialty Products stock?
PAH stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Beach Point Capital Management LP, Credit Suisse AG, JPMorgan Chase & Co., JPMorgan Chase & Co., First Manhattan Co., Frontier Capital Management Co. LLC and Cedar Hill Associates LLC. View Insider Buying and Selling for Platform Specialty Products.
Which major investors are buying Platform Specialty Products stock?
PAH stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Vaughan Nelson Investment Management L.P., Peregrine Capital Management LLC, Epoch Investment Partners Inc., BlackRock Inc., Locust Wood Capital Advisers LLC, Royce & Associates LP and Dimensional Fund Advisors LP. Company insiders that have bought Platform Specialty Products stock in the last two years include Benjamin Gliklich, Diego Lopez Casanello, Ian G H Ashken, John David Tolbert, John Edward Capps, Martin E Franklin, Pershing Square Capital Manage, Rakesh Sachdev and Scot Benson. View Insider Buying and Selling for Platform Specialty Products.
How do I buy shares of Platform Specialty Products?
Shares of PAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Platform Specialty Products' stock price today?
One share of PAH stock can currently be purchased for approximately $10.69.
How big of a company is Platform Specialty Products?
Platform Specialty Products has a market capitalization of $3.06 billion and generates $3.78 billion in revenue each year. The specialty chemicals company earns $-296,200,000.00 in net income (profit) each year or $0.76 on an earnings per share basis. Platform Specialty Products employs 7,850 workers across the globe.
What is Platform Specialty Products' official website?
How can I contact Platform Specialty Products?
Platform Specialty Products' mailing address is 1450 CENTREPARK BLVD SUITE 210, WEST PALM BEACH FL, 33401. The specialty chemicals company can be reached via phone at 561-207-9600.
MarketBeat Community Rating for Platform Specialty Products (NYSE PAH)
MarketBeat's community ratings are surveys of what our community members think about Platform Specialty Products and other stocks. Vote "Outperform" if you believe PAH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PAH will underperform the S&P 500 over the long term. You may vote once every thirty days.
